Page last updated: 2024-08-17

hydroxyproline and vasoactive intestinal peptide

hydroxyproline has been researched along with vasoactive intestinal peptide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Guan, CX; Luo, WJ; Sun, CC; Sun, GY; Tang, CY; Zhang, J; Zhang, YF; Zhou, Y	1

Other Studies

1 other study(ies) available for hydroxyproline and vasoactive intestinal peptide

Article	Year
Vasoactive intestinal peptide inhibits the activation of murine fibroblasts and expression of interleukin 17 receptor C. Cell biology international, 2019, Volume: 43, Issue:7 Topics: Actins; Animals; Collagen Type III; Disease Models, Animal; Fibroblasts; Hydroxyproline; Lipopolysaccharides; Male; Mice; NIH 3T3 Cells; Protein Kinase Inhibitors; Receptors, Interleukin; Receptors, Interleukin-17; Respiratory Distress Syndrome; Signal Transduction; Vasoactive Intestinal Peptide	2019

Article

Year

Vasoactive intestinal peptide inhibits the activation of murine fibroblasts and expression of interleukin 17 receptor C.

Cell biology international, 2019, Volume: 43, Issue:7

Topics: Actins; Animals; Collagen Type III; Disease Models, Animal; Fibroblasts; Hydroxyproline; Lipopolysaccharides; Male; Mice; NIH 3T3 Cells; Protein Kinase Inhibitors; Receptors, Interleukin; Receptors, Interleukin-17; Respiratory Distress Syndrome; Signal Transduction; Vasoactive Intestinal Peptide

2019